P15121 (ALDR_HUMAN) Homo sapiens (Human)

Aldo-keto reductase family 1 member B1 UniProtKBInterProSTRINGInteractive Modelling

316 aa; Sequence (Fasta) Identical sequences: Homo sapiens: A0A024R7A8

Sequence Features

 49Proton donor.
 78Lowers pKa of active site Tyr.
 15I -> F (in dbSNP:rs5054). VAR_014743 dbSNP
 42H -> L (in dbSNP:rs5056). VAR_014744 dbSNP
 73L -> V (in dbSNP:rs5057). VAR_014745 dbSNP
 90K -> E (in dbSNP:rs2229542). VAR_048213 dbSNP
 204G -> S (in dbSNP:rs5061). VAR_014746 dbSNP
 288T -> I (in dbSNP:rs5062). VAR_014747 dbSNP
 10-19NADP.
 211-273NADP.
 16-290NADP-dependent oxidoreductase domain
IPR023210PF00248

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASEhomo-2-mer NAP;FID;1ef32-316
'Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl...monomer NAP;4O8;4lbs1-316
'Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at ...monomer FIS;NAP;CIT;3bcj1-316
'Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)c...monomer NAP;4O9;4lbr1-316
'Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carba...monomer NAP;M15;4lb31-316
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)car...monomer NAP;1WX;4lb41-316
Human aldose reductase in complex with NADP and citrate at 0.82 angstrommonomer NAP;FLC;2j8t1-316
'Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophe...monomer NAP;W8X;4lau1-316
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064monomer 64I;NAP;4igs1-316
'Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phen...monomer 1WW;NAP;4laz1-316
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat...monomer NDP;LDT;CIT;FID;CL;2pf81-316
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat...monomer NDP;LDT;CIT;FID;CL;2pev1-316
AKR1B1 at 0.03 MGy radiation dose.monomer NAP;CIT;6f7r1-316
Crystal structure of human Aldose Reductase complexed with NADP and Fidarestatmonomer NAP;FID;CL;1pwm1-316
Crystal structure of human AKR1B1 complexed with NADP+ and compound 37monomer AV5;NAP;5ou01-316
Human Aldose Reductase mutant T113V complexed with IDD388monomer 388;NAP;BR;CIT;3m4h1-316
Crystal structure of human AKR1B1 complexed with NADP+ and compound 41monomer AVT;NAP;5ouk1-316
'Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC A...monomer NAP;2WB;4prt1-316
Crystal structure of human AKR1B1 complexed with NADP+ and compound 39monomer NAP;AW8;5ouj1-316
AKR1B1 at 0.75 MGy radiation dose.monomer NAP;CIT;6f811-316
Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl...monomer NAP;30L;CIT;4qbx1-316
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global ef...monomer NDP;CIT;LDT;3ghr1-316
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global ef...monomer NDP;CIT;LDT;3ghs1-316
Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestatmonomer NAP;CIT;FID;CL;2agt1-316
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048monomer NAP;48I;4xzh1-316
'The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specifici...monomer 393;NAP;2pzn1-316
'Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) ...monomer 53N;NAP;4yu11-316
AKR1B1 at 1.65 MGy radiation dose.monomer NAP;CIT;6f821-316
Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrommonomer NDP;3NA;1z3n1-316
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-yl...monomer NAP;37V;4qr61-316
Crystal structure of human aldose reductase complexed with NADP and IDD552monomer NAP;ID5;1t411-316
Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A.monomer NAP;4G7;4ys11-316
Human Aldose Reductase mutant T113V in complex with Zopolrestatmonomer ZST;NAP;3m0i1-316
AKR1B1 at 2.55 MGy radiation dose.monomer NAP;CIT;6f841-316
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global ef...monomer NDP;CIT;LDT;3ght1-316
Crystal structure of human Aldose Reductase complexed with NADP and Minalrestatmonomer BFI;NAP;1pwl1-316
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylc...monomer 2WQ;NAP;CIT;4puw1-316
'Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-ph...monomer NAP;2WR;4puu1-316
Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1monomer 393;NAP;3mc51-316
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global ef...monomer NDP;CIT;LDT;3ghu1-316
Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 Amonomer NAP;3E2;4qx41-316
Human aldose reductase in complex with a nitrile-containing IDD inhibitormonomer 3T4;NAP;CIT;3t421-316
Human aldose reductase mutant T113V complexed with IDD393monomer 393;NAP;3m641-316
Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S)monomer FIS;NAP;CIT;1x981-316
Crystal structure of Aldose Reductase with citrates bound in the active sitemonomer NAP;CIT;1x961-316
Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S)monomer FIR;NAP;1x971-316
Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitormonomer NAP;62P;1z891-316
Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 Amonomer NAP;BTO;2ikg1-316
Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution.monomer NAP;TOL;2fzb1-316
Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121monomer NAP;SO4;3q671-316
Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121monomer NAP;SO4;WY1;5ha71-316
Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductasemonomer NAP;DOY;3p2v1-316
HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITORmonomer NAP;I84;1el31-316
Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5monomer NAP;ID5;1t401-316
Human aldose reductase complexed with IDD 740 inhibitormonomer NDP;Q74;3g5e1-316
Crystal Structure of Human Aldose Reductase Complexed with Tolmetinmonomer NAP;TLT;3s3g1-316
Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfonemonomer NAP;SLO;3rx21-316
Crystal Structure of Human Aldose Reductase Complexed with Sulindacmonomer NAP;SUZ;3rx31-316
Aldose reductase complexed with a nitro compoundmonomer NTI;NAP; 23×DMF;3v351-316
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Epalrestatmonomer NAP;EPR;SO4;4jir1-316
Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfidemonomer NAP;SFI;3rx41-316
Aldose reductase complexed with glceraldehydemonomer NAP;3GR;0PY;3v361-316
Human Aldose Reductase in Complex with NADP+ in Space Group P212121monomer GOL;NAP;SO4;3q651-316
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049monomer F49;NAP;4xzi1-316
Human Aldose Reductase structuremonomer NAP;LDT;2r241-316
Complex of Aldose Reductase with inhibitor IDD 1219monomer 2X9;NAP;4gca2-316
Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitormonomer NAP;62P;1z8a2-316
Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolutionmonomer NAP;PG4;PG5;CIT;PEG;SUZ;3u2c2-316
'Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)a...monomer 2W9;NAP;4prr2-316
Human Aldose Reductase complexed with Schl7802 at 1.06 Amonomer 2W8;NAP;4pr42-316
Human aldose reductase mutant T113C complexed with IDD594monomer NAP;CIT;BR;LDT;3lbo2-316
'Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-flu...monomer NAP;2YZ;4q7b2-316
Aldose Reductase in complex with novel biarylic inhibitormonomer 53N;NAP;3dn52-316
Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A.monomer NAP;47D;2pdh2-316
Human aldose reductase mutant L301M complexed with tolrestat.monomer NAP;TOL;2pdl2-316
Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking).monomer ZST;NAP;2fz82-316
Human aldose reductase mutant C303D complexed with IDD393.monomer 393;NAP;2pdu2-316
Human aldose reductase mutant C303D complexed with fidarestat.monomer NAP;FID;2pdw2-316
Human aldose reductase mutant V47I complexed with fidarestat.monomer NAP;FID;2pd92-316
'Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2)'monomer NAP;ITB;2nvd2-316
Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 Amonomer LIT;NAP;2ikh2-316
Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A.monomer ZST;NAP;2pdi2-316
Human aldose reductase complexed with nitro-substituted IDD-type inhibitormonomer 393;NAP;2ikj2-316
Human aldose reductase mutant L301M complexed with sorbinil.monomer NAP;SBI;2pdk2-316
Human aldose reductase mutant L300A complexed with IDD393.monomer 393;NAP;2pdj2-316
'Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_coc...monomer ZST;NAP;2hvn2-316
'Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3da...monomer ZST;NAP;2dux2-316
'Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2)'monomer ZST;NAP;2duz2-316
Human aldose reductase mutant V47I complexed with zopolrestatmonomer ZST;NAP;2pd52-316
Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking.monomer ZST;NAP;2fz92-316
Human aldose reductase mutant F121P complexed with zopolrestat.monomer ZST;NAP;2pdb2-316
Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst)monomer ZST;NAP;2hvo2-316
Human aldose reductase mutant S302R complexed with IDD 393.monomer 393;NAP;2pdp2-316
AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HO...monomer NAP;1ads2-316
Human aldose reductase double mutant S302R-C303D complexed with fidarestat.monomer NAP;FID;2pdy2-316
Human aldose reductase mutant F121P complexed with IDD393.monomer 393;NAP;2pdc2-316
'Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3)'monomer NAP;ITA;2nvc2-316
Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acidmonomer 2CL;NAP;2is72-316
Human aldose reductase mutant S302R complexed with uracil-type inhibitor.monomer NAP;47D;2pdn2-316
Human aldose reductase mutant C303D complexed with uracil-type inhibitor.monomer NAP;47D;2pdq2-316
Human aldose reductase mutant S302R complexed with zopolrestat.monomer ZST;NAP;2pdm2-316
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITR...monomer G6P;NAP;2acq2-316
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITR...monomer CAC;NAP;2acr2-316
TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN...monomer NAP;CIT;2acu2-316
'REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZO...monomer ZST;NAP;1mar2-316
Aldose reductase tertiary complex with NADPH and DEGmonomer NDP;TGG;2f2k2-316
Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic Acidmonomer NAP;OHP;2inz2-316
Crystal Structure of Aldose Reductase complexed with Lipoic Acidmonomer NAP;LPA;2iqd2-316
Apo R268A human aldose reductasemonomer 1xgd2-316
CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT.monomer ZES;NAP;1iei2-316
Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrommonomer NDP;CIT;LDT;1us01-314
Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15Kmonomer NDP;CIT;LDT;2i161-314
Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60Kmonomer NDP;CIT;LDT;2i171-314
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat...monomer NDP;LDT;CIT;FID;CL;2pfh1-314
Crystal structure of human AR complexed with NADP+ and AK198monomer NAP;I98;4qxi1-314
Human Aldose Reductase mutant T113C in complex with IDD388monomer 388;NAP;BR;CIT;3lep1-314
Human Aldose Reductase complexed with Schl7764 at 1.12 Amonomer NAP;2HZ;4nkc3-316
AKR1B1 at 3.45 MGy radiation dose.monomer NAP;CIT;6f8o1-314
Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1)monomer NAP;3UH;4rpq3-316
Human Aldose Reductase mutant T113S complexed with Zopolrestatmonomer ZST;NAP;3len3-316
Human aldose reductase with uracil-type inhibitor at 1.42A.monomer NAP;47D;2pdg3-316
Human aldose reductase mutant L300P complexed with zopolrestat.monomer ZST;NAP;2pdf3-316
'Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soak...monomer ZST;NAP;2hv53-316
Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2)monomer ZST;NAP;2dv03-316
Human Aldose Reductase mutant T113A complexed with Zopolrestatmonomer ZST;NAP;3mb93-316
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITR...monomer NAP;CIT;2acs3-316
ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASEmonomer NAP;ALR;1az13-316
Crystal Structure of Aldose Reductase complexed with Phenylacetic Acidmonomer NAP;PAC;2ine3-316
Crystal Structure of Aldose Reductase complexed with Hexanoic Acidmonomer NAP;6NA;2iq03-316
Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acidmonomer 2CL;NAP;2ipw3-316
Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic Acidmonomer NAP;PAC;2isf3-316
THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEXmonomer NDP;1abn3-316
CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASEmonomer NAP;CIT;1az23-316
Perdeuterated alr2 in complex with idd594monomer NDP;CIT;LDT;2qxw1-313
Human aldose reductase mutant T113V complexed with IDD594monomer NAP;CIT;LDT;3lz51-313
Human aldose reductase mutant T113S complexed with IDD388monomer 388;NAP;BR;CIT;3lz31-313
Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A ...monomer NAP;CIT;BR;LDT;3onc2-314
Human aldose reductase complexed with tolrestat at 1.08 A resolution.monomer NAP;TOL;2fzd1-313
Human Aldose Reductase mutant T113A complexed with IDD 594monomer NAP;CIT;BR;LDT;3lql1-313
Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A ...monomer NAP;CIT;BR;LDT;3onb2-313
Human aldose reductase double mutant S302R-C303D complexed with zopolrestat.monomer ZST;NAP;2pdx2-313
Human aldose reductase mutant T113S complexed with IDD594monomer NAP;CIT;BR;LDT;3ld53-313
Human aldose reductase mutant T113A complexed with IDD388monomer 388;NAP;BR;3lqg3-313
Human aldose reductase complexed with halogenated IDD-type inhibitormonomer 388;NAP;2iki2-312